Clinical trial
PROSEVO Trial (Propofol-Sevoflurane Delirium Target Trial Emulation)
NCT07612579 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROSEVO Trial (Propofol-Sevoflurane Delirium Target Trial Emulation)
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 3, 2026
- Completion date
- December 31, 2027
- Enrollment
- 100,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative delirium